Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-21

Development of neuroprotective leadstructures derived from neuropeptid qynad

Ziel

Genopia Biomedical GmbH is a European biotechnology company focused on -Drug Development and Target Discovery -Protein Interaction Screening -Rational Designed Protein BioChips We are currently offering two fellow positions/looking for two individuals (1 postgraduate, 1 postdoc) with background in protein-chemistry and hands-on experience in one or more of following techniques: 2D-electrophoresis, mass spectrometry, functional characterization of proteins, pull-down-assays and immuno- precipitation, protein biochip technologies. In close cooperation with our R&D partner institution at the University of Ulm the candidates will be involved in cutting-edge research with world leading experts in neurophysiology in area of multiple sclerosis and ion channel research. Their task will be the investigation of neuroprotective peptides: Identification of target proteins; Isolation of precursorpeptide; Screening of a peptide library; Electrophysiological testing of peptides. Genopia will offer the fellows active support during their stay and the experienced research group at the University of Ulm will provide a sound scientific basis.

Wissenschaftliches Gebiet (EuroSciVoc)

Programm/Programme

Thema/Themen

Daten nicht verfügbar

Aufforderung zur Vorschlagseinreichung

Daten nicht verfügbar

Finanzierungsplan

BUR - Bursaries, grants, fellowships

Koordinator

GENOPIA BIOMEDICAL GMBH
EU-Beitrag
Keine Daten
Adresse
Albert-Einstein-Allee 11
89069 ULM
Deutschland
Gesamtkosten
Keine Daten